concizumab
Showing 1 - 7 of 7
Congenital Haemophilia Trial in United States (Concizumab)
Available
- Congenital Haemophilia
- Concizumab
-
Chicago, Illinois
- +9 more
Jan 5, 2023
Haemophilia A and B With and Without Inhibitors Trial in Worldwide (Concizumab)
Recruiting
- Haemophilia A and B With and Without Inhibitors
- Concizumab
-
San Diego, California
- +55 more
Feb 2, 2023
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (Concizumab,
Completed
- Congenital Bleeding Disorder
- +2 more
- Concizumab
- Eptacog alfa
-
Los Angeles, California
- +21 more
Sep 24, 2021
Haemostasis, Haemophilia A Trial in Worldwide (Concizumab, Turoctocog alfa)
Completed
- Haemostasis
- Haemophilia A
- Concizumab
- Turoctocog alfa
-
Los Angeles, California
- +30 more
Nov 15, 2021
Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (Concizumab)
Active, not recruiting
- Haemophilia A With Inhibitors
- Haemophilia B With Inhibitors
- Concizumab
-
Orange, California
- +77 more
Dec 29, 2022
Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors Trial in Worldwide (Concizumab)
Active, not recruiting
- Haemophilia A Without Inhibitors
- Haemophilia B Without Inhibitors
- Concizumab
-
Los Angeles, California
- +88 more
Feb 2, 2023
Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Concizumab, )
Completed
- Congenital Bleeding Disorder
- Haemophilia A
- Concizumab
- placebo
-
Torrance, California
- +33 more
Jul 20, 2017